Related Experiment Video
Updated: Aug 8, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Minimum effective dose of dexamethasone after tonsillectomy
Varol Celiker1, Nalan Celebi, Ozgür Canbay
1Department of Anaesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Insights
This study found no significant difference in postoperative vomiting between different doses of dexamethasone combined with ondansetron in children undergoing tonsillectomy. Standardized surgical and anesthetic techniques may have contributed to low nausea and vomiting incidence.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
Background:
- Postoperative nausea and vomiting (PONV) is a common complication after pediatric tonsillectomy.
- Evaluating the minimum effective dose of dexamethasone with ondansetron for PONV is crucial.
Purpose of the Study:
- To determine the minimum effective dose of dexamethasone in combination with ondansetron for treating postoperative vomiting.
- To assess the impact of varying dexamethasone doses on PONV in children undergoing elective tonsillectomy or adenotonsillectomy.
Main Methods:
- A prospective, randomized, double-blind study involving 102 children aged 2-12 years.
- Administration of intravenous dexamethasone (50, 100, 150 µg/kg) with ondansetron (50 µg/kg) before surgery.
- Standardized anesthesia (sevoflurane, N2O/O2) and surgical techniques, with a saline control group.
Main Results:
- No significant differences were observed in postoperative vomiting incidence between the groups.
- The need for postoperative pain medication and supplementary antiemetics did not differ significantly across groups (P > 0.05).
Conclusions:
- The study suggests that standardized surgical and anesthetic management may be responsible for the low incidence of PONV.
- Further studies with larger patient cohorts may yield different results regarding the efficacy of dexamethasone and ondansetron for PONV.
Background:
The minimum effective dose of dexamethasone in conjunction with 50 microg x kg(-1) ondansetron was evaluated in the treatment for vomiting after elective tonsillectomy or adenotonsillectomy.
Methods:
A total of 102 healthy children between 2 and 12 years of age participated in this prospective, randomized, double-blind study. A single intravenous (i.v.) dose of dexamethasone (50, 100, 150 microg x kg(-1), maximum dose 8 mg) with ondansetron (50 microg x kg(-1)) was administered just before the end of surgery. Equal volumes of normal saline were given to the control group. General anaesthesia was induced and maintained by inhalation of N2O/O2 and sevoflurane. All other preoperative and postoperative medications (including a supplementary dose of antiemetics if necessary), anaesthesia and surgical techniques were standardized.
Results:
No significant differences were observed between groups in postoperative vomiting on the day of surgery and the next day, or in the need for postoperative pain medication and supplementary doses of antiemetics (P > 0.05).
Conclusions:
These results indicate that surgical technique and anaesthetic management used in this study could be the cause of the lower incidence of nausea and vomiting. Assessment of nausea and vomiting in a prospective study with larger groups of patients may reflect different results.
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Dosage Regimen: Multiple Oral Dosage
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
IV Infusion to Oral Dosing: Conversion Methods

